UnitedHealth Group and Amedisys have pushed back the closure date for their $3.3 billion merger as they fend off a federal ...

On Monday, shares of Amedisys (NASDAQ:AMED), a healthcare company with a market capitalization of $2.95 billion, remained steady following the announcement of an extension to its merger agreement ...

The acquisition was originally expected to close this month, but in November the DOJ sued to block the merger.

On Monday, shares of Amedisys (NASDAQ:AMED), a healthcare company with a market capitalization of $2.95 billion, remained steady following the announcement of an extension to its merger agreement with ...

Amedisys' expected merger with UnitedHealth Group's Optum brings optimism to investors. Yet, a dull macroeconomic condition adds to the worry.

Amedisys' expected merger with UnitedHealth Group's Optum brings optimism to investors. Yet, a dull macroeconomic condition adds to the worry. In a regulatory filing, Amedisys (AMED) stated ...

The firm's analysis points to a stable outlook for Amedisys stock, anchored by the anticipated benefits of the merger with UnitedHealth Group. With a beta of 0.73 and revenue growth of 4.19% in ...

The firm's analysis points to a stable outlook for Amedisys stock, anchored by the anticipated benefits of the merger with UnitedHealth Group. With a beta of 0.73 and revenue growth of 4.19% in the ...

Amedisys Inc.’s (AMED) shares climbed 4.7% following news that the company extended the deadline to close its $3.3 billion merger plan with UnitedHealth Group Inc. (UNH). Shares of Lamb Weston ...

Warren Buffett has spent more than $70 million over six days to Dec. 24 to resume buying VeriSign's stock. Stronger-than-expected holiday cinema audiences brought North American box office totals to ...